Vertex Pharmaceuticals
VRTX
#178
Rank
$114.63 B
Marketcap
$447.12
Share price
0.56%
Change (1 day)
-4.71%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: $114.63 Billion USD

As of December 2025 Vertex Pharmaceuticals has a market cap of $114.63 Billion USD. This makes Vertex Pharmaceuticals the world's 178th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025$114.63 B8.9%
2024$105.26 B0.4%
2023$104.84 B41.44%
2022$74.12 B32.63%
2021$55.88 B-9.06%
2020$61.45 B8.38%
2019$56.70 B34.11%
2018$42.28 B11.57%
2017$37.90 B107.41%
2016$18.27 B-41.04%
2015$30.99 B7.91%
2014$28.72 B65.35%
2013$17.37 B90.79%
2012$9.10 B31.44%
2011$6.92 B-2.85%
2010$7.12 B-16.79%
2009$8.56 B99.27%
2008$4.29 B39.3%
2007$3.08 B-34.6%
2006$4.71 B57.7%
2005$2.99 B250.55%
2004$0.85 B5.71%
2003$0.80 B-33.27%
2002$1.21 B-34.42%
2001$1.84 B-56.7%
2000$4.26 B374.13%
1999$0.89 B19.16%
1998$0.75 B-9.34%
1997$0.83 B-2.01%
1996$0.84 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Vertex Pharmaceuticals was reported to be:

$112.81 Billion USD
by Nasdaq info icon info icon
$114.00 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
$152.72 B 33.22%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$397.92 B 247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$246.73 B 115.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$104.40 B-8.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$508.57 B 343.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
$0.41 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA